Plenary Speakers

  • Wednesday, April 15: Amy Abernethy, MD, PhD
  • Thursday, April 16: Consuelo H. Wilkins, MD, MSCI
  • Friday, April 17: Kirsten Bibbins-Domingo, PhD, MD, MAS



Amy Abernethy, MD, PhD

Learn more about her education, work history and experience.

As the Principal Deputy Commissioner of Food and Drugs, Dr. Amy P. Abernethy, MD, PhD, helps oversee the agency's day-to-day functioning and directs special and high-priority initiatives that cut across officers overseeing FDA's regulation of drugs, medical devices, tobacco and food. 

Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized clinical data expert and clinical researcher. Her areas of expertise include cancer data, real world evidence, clinical trials, health services research, patient reported outcomes (PROs), clinical informatics, and patient-centered care. 

Before coming to FDA, Dr. Abernethy served at the chief medical officer, chief scientific officer, and senior vice president for oncology at Flatiron Health (a member of the Roche Group, where she led the research oncology, clinical operations and data science teams, and contributed to the overall strategic vision of the company, including directing their research vision on real world evidence.

Prio to that. Dr. Abernethy was professor of medicine at Duke University School of Medicine, where she ran the Center for Learning Health Care in the Duke Clinical Research Institute and the Duke Cancer Care Research Program in the Duke Cancer Institute. At Duke, she pioneered the development of technology platforms to spur novel advancements in the care of people with cancer and other serious life-limiting illnesses. 

Dr. Abernethy was formerly appointed member of the National Academy of Medicine's National Cancer Policy Forum, an elected member of the American Society for Clinical Investigation, and Past President of the American Academy of Hospice & Palliative Medicine. 

Dr. Abernethy received her MD at Duke University, where she also did her internal medicine residency, served as chief resident, and completed her hematology/oncology fellowship. She received her PhD from Flinders University in Australia, with a focus on evidence-based medicine and clinical informatics, and her bachelor's degree from the University of Pennsylvania.

See what areas her presentation will cover and key takeaways. 

Consuelo H. Wilkins, MD, MSCI

Learn more about her education, work history and experience.

Dr. Consuelo H. Wilkins--a geriatrician, clinical investigator and engagement scientist --is Vice President for Health Equity at Vanderbilt University Medical Center and Executive Director of the Meharry-Vanderbilt Alliance. Dr. Wilkins is Associate Dean for Health Equity and a Professor of Medicine at Vanderbilt University School of Medicine. As a Principal Investigator of the Vanderbilt Clinical and Translational Science Award, she oversees programs in community engagement, team science and special populations. Dr. Wilkins is also a Principal Investigator of two other NIH-funded centers, the Vanderbilt-Miami-Meharry Center of Excellence in Precision Medicine and Population Health, which focuses on decreasing disparities among African Americans and Latinos using precision medicine; and the Vanderbilt Recruitment Innovation Center, a national center dedicated to enhancing recruitment and retention in clinical trials.

Dr. Wilkins has developed innovative approaches to engagement and has led comprehensive, multi-level stakeholder engagement efforts at the local and national level. She is currently Director of the Engagement Core of the All of Us Research Program, a national precision medicine initiative, which will enroll at least one million participants, and she leads engagement for the STAR Clinical Research Network. As Principal Investigator of a Patient Centered Outcomes Research Institute (PCORI) Methods Award on understanding and improving patient engagement in research, Dr. Wilkins led the development of a new tools to advance the science of engagement including the Person-Centeredness of Research Scale and a taxonomy of the impacts of engagement on research. Dr. Wilkins is also a Principal Investigator of a Robert Wood Johnson Foundation award –Engendering Trust in Health Care among African American Men. 

Prior to her current roles, she was an Associate Professor in the Department of Medicine, Division of Geriatrics, with secondary appointments in Psychiatry and Surgery (Public Health Sciences) at Washington University School of Medicine. There she served as founding director of the Center for Community Health and Partnerships in the Institute for Public Health and Co-Director of the Center for Community Engaged Research in the CTSA.

Dr. Wilkins earned a Bachelor of Science in microbiology and Doctor of Medicine from Howard University.  She completed a residency in Internal Medicine at Duke University Medical Center and a Geriatric Medicine fellowship at Washington University School of Medicine/Barnes-Jewish Hospital. Following her medical training, she earned a Master of Science in Clinical Investigation from Washington University School of Medicine.

See what areas her presentation will highlight and key takeaways.

Kirsten Bibbins-Domingo, PhD, MD, MAS

Learn more about her education, work history and experience.

Kirsten Bibbins-Domingo, PhD, MD, MAS is the Lee Goldman, MD Endowed Chair in Medicine, Professor and Chair of the Department of Epidemiology and Biostatistics, and Professor of Medicine at the University of California, San Francisco. She is the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. She co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, a research center focused on discovery, implementation, policy, advocacy, and community engagement for communities at risk for poor health and inadequate healthcare. She is one of the Principle Investigators for the UCSF Clinical and Translational Sciences Institute.

Dr. Bibbins-Domingo is a general internist and cardiovascular epidemiologist who uses observational epidemiology, pragmatic trials, and simulation modeling to examine the impact of clinical and public health approaches to cardiovascular disease prevention in the US, in US population subgroups, and in other countries globally. She is an expert in prevention and previously served on the US Preventive Services Task Force as a member (2010-2017) and as vice chair and chair (2014-2017). She is an inducted member of the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.

See what areas her presentation will highlight and key takeaways.